2024-08-01 20:00:00
After a thorough analysis, the Federal Commission for Protection against Health Hazards (Cofepris) to authorize the Paxlovid drug sales. This is a historical fact because previously this drug was reserved for the health sector and could not be sold in our country.
Through a sentence Today the order of health registration was announced Paxlovid (nirmatrelvir/ritonavir), from the laboratory Pfizer. It is a treatment indication for adults with Covid-19 who do not require supplemental oxygen and those who are at high risk of disease progression.
Paxlovid, the first oral treatment against Covid-19
At that time, the drug made history because it was the first oral antiviral developed in the world for the treatment of disease caused by SARS-CoV-2 virus. He has tablets Nirmatrelvir and ritonavir and it even has the approval of the World Health Organization (WHO).
Why did Cofepris authorize the sale of Paxlovid?
The decision is based on the assessment of the New Molecules Committee (CMN) and the rigorous technical analysis carried out by the agency’s specialized team. In the end they decided that the medicine meets the quality, safety and efficacy requirements, according to the information presented in the technical file.
Thanks to these results, the open marketing of the first drug to prevent hospitalization and death from COVID-19 is authorized. An important point is that the Cofepris became one of the first regulatory agencies to authorize a medical registration of this type for the drug.
What other health centers in the world have authorized the sale of Paxlovid?
- United States Food and Drug Administration (FDA)
- Health Canada
- European Medicines Agency (EMA)
- Brazil’s National Health Inspection Agency (Anvisa)
- National Institute of Medicine of Chile (Name)
What kind of people is Paxlovid indicated for?
Just like us bulletin board Published by the Ministry of Health (SSa) in 2023, Paxlovid is indicated for people between the ages of 18 and 49 with Covid-19 who meet any of the following conditions.
- Lung diseases (asthma, COPD, among others).
- HIV without adequate control.
- Active cancer.
- Liver diseases.
- Uncontrolled diabetes.
- Obesity
- Heart attack.
- The use of drugs that reduce the response of the immune system.
- Uncontrolled arterial hypertension.
- Chronic kidney disease (GFR greater than 30 ml).
Is a prescription required to buy Paxlovid?
During the following days there will be Paxlovid in pharmacy countries. Although for its acceptance it is necessary to present it war because its free sale is not allowed.
In that way, Cofepris emphasizes that health professionals must evaluate the use and risk factors of the information in the prescription letter to avoid abuse, self-medication and illegal marketing.
This medication must be administered under strict medical supervision. Therefore, Cofepris urges the population to avoid the reckless use of vaccines or treatments against COVID-19. Incorrect application can represent health risks and if any adverse event occurs, it should be reported at the following link.
The health registration of Paxlovid is the result of extensive regulatory work by this health agency, in addition to collaboration with the manufacturing laboratory, to expand the available treatment options for COVID-19.
Cofepris joins the international call to remind the population that this treatment does not replace the prescribed vaccines against COVID-19 and should not be used without medical indication.
Also read:
#Cofepris #authorized #sale #drug #Paxlovid